Nivalis Therapeutics, Inc.'s Exec Vice President / COO just picked up 10,000 shares

Janice Troha, Nivalis Therapeutics, Inc.'s Exec Vice President / COO, recently acquired 10,000 shares of the company. The buys took place at $2.34 per share, on May 05, 2017. Troha now owns 10,000 shares of the company. Troha operates out of Boulder, CO. Some additional info was provided as follows:

The price recorded in Column 4 represents the actual price for the full block purchase.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Nivalis Therapeutics, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Confidential treatment order - March 19, 2019
Securities to be offered to employees in employee benefit plans - March 18, 2019
Securities to be offered to employees in employee benefit plans - March 18, 2019
General form for registration of securities under the Securities Act of 1933 - March 18, 2019
Nivalis Therapeutics, Inc. Just Filed Its Annual Report: Net Loss Per ShareBa... - March 18, 2019

Auto Refresh

Feedback